Browse Diagnostic reagents industry topic

Officials and employees subtopic

Articles 1-49 out of 49 article(s) Title Author Type Date Words AlliedPath. Pappas, Molly Brief article Nov 9, 2009 95 NeoPharm Names Dr. Aquilur Rahman as President and CEO. Oct 29, 2009 724 New CEO bryant offers quick view of Quidel. DiRamio, Denise Oct 1, 2009 604 Quidel Announces Executive Appointments. Aug 6, 2009 879 Zila Names Jon Plexico to Board of Directors. Apr 15, 2009 593 Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer. Jan 20, 2009 842 Luminex Corporation Announces Organizational Change. Jan 20, 2009 410 Avila Therapeutics Appoints Daniel S. Lynch as Executive Chairman. Dec 5, 2008 523 Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs. Nov 7, 2008 721 Osmetech plc ('Osmetech' or the 'Company') Board changes. Aug 12, 2008 421 ImClone Announces Changes in Commercial Organization Leadership. Jul 14, 2008 1899 Signature Reports Investment in Company and Appointment of New Chairman of Board of Directors. Jun 24, 2008 434 ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations. Jun 2, 2008 2150 ImClone Systems Reports First Quarter 2008 Financial Results. Financial report Apr 24, 2008 3527 ImClone Appoints Kenneth J. Zuerblis Chief Financial Officer. Mar 31, 2008 704 Aureon Laboratories Names Ana I. Stancic Chief Financial Officer. Mar 17, 2008 388 Dr. Kenneth F. Buechler Appointed to Quidel Corporation Board of Directors. Nov 6, 2007 727 ImClone Systems Appoints John H. Johnson Chief Executive Officer. Aug 9, 2007 560 Quidel Reports Strong Second Quarter Results. Jul 26, 2007 1378 ImClone Systems Appoints Thomas F. Deuel to Board of Directors. Jul 10, 2007 569 Quidel Announces Promotion of Scot M. McLeod to Senior Vice President, Operations. Jun 26, 2007 710 ImClone Systems Appoints Jules Haimovitz to Board of Directors. May 11, 2007 604 ImClone Systems Incorporated Appoints Andrew R. J. Bonfield to Board of Directors. Apr 26, 2007 559 NEOPHARM Names Laurence P. Birch as President and CEO. Mar 26, 2007 583 Palomar Pomerado Health. Bengtson, Stacey Jan 29, 2007 85 Quidel Corp. Bengtson, Stacey Brief article Jan 15, 2007 53 Quidel Names John M. Radak Chief Financial Officer. Jan 3, 2007 821 ImClone Systems. Brief article Jan 1, 2007 44 Carl C. Icahn Appointed Chairman of ImClone Systems. Oct 25, 2006 710 ImClone Systems Appoints Peter S. Liebert, M.D., to Board of Directors. Oct 20, 2006 498 Two Directors Resign from ImClone Systems Board of Directors. Oct 10, 2006 178 ImClone Systems Promotes Ana I. Stancic to Senior Vice President, Finance. Sep 28, 2006 577 ImClone Systems Promotes Michael P. Bailey to Senior Vice President, Commercial Operations; Ronald A. Martell, Senior Vice President, Commercial Operations, to Leave the Company. Aug 2, 2006 538 ImClone Systems Names Elizabeth Yamashita Vice President, Regulatory CMC and Operations. May 16, 2006 510 NeoPharm Announces Resignation of Chief Scientific Officer. May 3, 2006 438 ImClone Systems Appoints Alex Denner, Ph.D., to Board of Directors; Board of Directors Approves Amendment to Stockholder Rights Plan. May 2, 2006 597 ImClone Systems Promotes Richard Crowley to Senior Vice President, Biopharmaceutical Operations; Joseph Tarnowski, Ph.D., Senior Vice President, Manufacturing Operations and Product Development, to Leave the Company. Feb 9, 2006 546 Quidel Corporation Appoints Jack W. Schuler and Rod F. Dammeyer to Its Board of Directors. Feb 7, 2006 871 ImClone Systems Engages Lazard to Review Strategic Alternatives for the Company; ImClone Systems Announces Joseph L. Fischer, Director, Named Interim Chief Executive Officer. Jan 24, 2006 693 ImClone Systems Names Cheryl Anderson Vice President, Regulatory Affairs. Jan 3, 2006 547 Daniel S. Lynch Resigns as CEO of ImClone Systems; Philip Frost, M.D., Ph.D., Named Interim CEO; Board Initiates External Search for Permanent Replacement. Nov 10, 2005 678 Digene's chairman/CEO Evan Jones: discusses disease-specific molecular diagnostic tests, women's health issues and consumer health advocacy. (Expert Opinion). Interview Jul 1, 2003 1442 Did Waksal's crime deserve the time? (A Special Report: Scoring L.A.'s Public Companies). Woolner, Ann Jun 23, 2003 820 Ostex International appoints Fredric J. Feldman, Ph.D., to its board of directors. May 1, 1997 435 North American Scientific Inc. expands management base. Apr 30, 1997 430 Ostex announces management changes. Apr 29, 1997 372 Gamma Biologicals Realigns Management Team. Oct 8, 1996 515 BDI appoints VP of Business Development from Beckman Instruments. Oct 8, 1996 241 InVitro International selects senior vice president -- general manager of its customized technology services; Dennis Chenoweth brings focus and wealth of experience to stimulate company's marketing and sales efforts. Feb 28, 1995 430